13FPulse
中
BD

BDTX BLACK DIAMOND THERAPEUTICS I

2026Q2 · CUSIP 09203E105 · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it
94
Institutions that reported holding it to the SEC
Net decrease in holders
4
Last quarter 98 → now 94
How unusual is that
Below average
Stronger than only 23% of US stocks
What the filings say, in one paragraph

94 funds held BDTX at the end of 2026Q2, down 4 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, revenue over the last 12 months was $0(YoY -100.0%), return on equity is -44.3%. BDTX has had 2 buying rushes in its history, and the price moved +22.6% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2020Q1: holders=64 2020Q2: holders=78 2020Q3: holders=85 2020Q4: holders=108 2021Q1: holders=114 2021Q2: holders=101 2021Q3: holders=99 2021Q4: holders=94 2022Q1: holders=86 2022Q2: holders=74 2022Q3: holders=69 2022Q4: holders=59 2023Q1: holders=50 2023Q2: holders=74 2023Q3: holders=73 2023Q4: holders=76 2024Q1: holders=88 2024Q2: holders=90 2024Q3: holders=95 2024Q4: holders=87 2025Q1: holders=85 2025Q2: holders=94 2025Q3: holders=91 2025Q4: holders=103 2026Q1: holders=98 2026Q2: holders=94 -63 -31.5 +0 +31.5 +63 4583120 20Q120Q421Q322Q223Q123Q424Q325Q226Q126Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 2 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2023Q2 Top 10% -32.5% +64.3%
2020Q1 Top 1% in the market -26.8% -19.1%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
60
Change in large funds
+6
Total value they hold
$64M
Funds buying for the first time
31
Funds that sold out entirely
35
Price change that quarter
—
Funds holding puts (bearish)
2
Funds holding calls (bullish)
4

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
—
EPS (TTM)
$-0.73
EPS YoY
-417.4%
Revenue (TTM)
$0.0B
Revenue YoY
-100.0%
Net margin
—
ROE
-44.3%
Debt ratio
23.2%
FCF (TTM)
—
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.97 2021-12-31: EPS -0.71 2022-03-31: EPS -0.70 2022-06-30: EPS -0.63 2022-09-30: EPS -0.60 2022-12-31: EPS -0.59 2023-03-31: EPS -0.57 2023-06-30: EPS -0.52 2023-09-30: EPS -0.45 2023-12-31: EPS -0.34 2024-03-31: EPS -0.35 2024-06-30: EPS -0.36 2024-09-30: EPS -0.28 2024-12-31: EPS -0.28 2025-03-31: EPS 0.98 2025-06-30: EPS -0.19 2025-09-30: EPS -0.15 2025-12-31: EPS -0.25 2026-03-31: EPS -0.16 2026-06-30: EPS -0.17 0M 35M 70M $M -1.07 0.01 1.08 20182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
5 20 34 20252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-29M-14M0K 20192020202120222023202420252026
Latest quarter $-15M (2024-12-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.